Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1002/ALZ.70037 | ||||
| Año | 2025 | ||||
| Tipo | revisión |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
INTRODUCTION Global life expectancy has steadily increased in recent decades, resulting in a significant rise in the number of individuals aged 80 years and older. This trend is also evident in Latin America, where life expectancy is improving, though at varying rates across countries and regions. METHODS Partnering with the Neurosciences Group of Antioquia (GNA), we launched a Colombian study on resilience in families with autosomal dominant Alzheimer's disease and the oldest-old population. Over the past 2 years, the project has expanded to include participants from Peru, Chile, and Costa Rica. RESULTS This research led to the first symposium on Brain Resilience and Healthy Longevity, held in Medell & iacute;n, Colombia, in August 2024. DISCUSSIONThe article summarizes key discussions from the symposium, highlighting the most promising opportunities for brain resilience and prevention research in the region and offering recommendations for future research to promote healthy aging and dementia-free communities. Highlights Uncovering the genetic and physiological drivers of cognitive resilience, neurodegeneration resistance, and healthy longevity is essential for maintaining brain function as we age. "Superagers" and cognitively resilient individuals from Latin American families with Alzheimer's disease offer valuable insights into brain protection mechanisms. Studying the interplay of socio-environmental and genetic factors in the oldest-old is key to understanding healthy longevity and improving dementia prevention. The inaugural Brain Resilience and Healthy Longevity Symposium highlights the need for global collaboration to uncover factors that drive cognitive resilience and healthy aging in Latin America, advancing dementia prevention.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Quiroz, Yakeel T. | - |
Harvard Med Sch - Estados Unidos
BOSTON UNIV - Estados Unidos UNIV ANTIOQUIA - Colombia Massachusetts General Hospital - Estados Unidos Boston University - Estados Unidos Universidad de Antioquia - Colombia |
| 2 | Aguillon, David | - |
UNIV ANTIOQUIA - Colombia
Universidad de Antioquia - Colombia |
| 3 | Arboleda-Velasquez, Joseph | - |
Harvard Med Sch - Estados Unidos
Harvard Medical School - Estados Unidos |
| 4 | Bocanegra, Yamile | - |
UNIV ANTIOQUIA - Colombia
Universidad de Antioquia - Colombia |
| 5 | CARDONA-GOMEZ, GLORIA PATRICIA | Mujer |
UNIV ANTIOQUIA - Colombia
Universidad de Antioquia - Colombia |
| 6 | Corrada, Maria M. | - |
Univ Calif Irvine - Estados Unidos
UCI School of Medicine - Estados Unidos University of California, Irvine - Estados Unidos |
| 7 | Diez, Ibai | - |
Harvard Med Sch - Estados Unidos
Biobizkaia Hlth Res Inst - España Ikerbasque - España Massachusetts General Hospital - Estados Unidos Barakaldo - España Ikerbasque, Basque Foundation for Science - España |
| 8 | Garcia-Cifuentes, Elkin | - |
UNIV ANTIOQUIA - Colombia
Pontificia Univ Javeriana - Colombia Universidad de Antioquia - Colombia Universidad Javeriana Facultad de Medicina - Colombia |
| 9 | Kosik, Kenneth | - |
UNIV CALIF SANTA BARBARA - Estados Unidos
University of California, Santa Barbara - Estados Unidos |
| 10 | Martinez, Lusiana | - |
Harvard Med Sch - Estados Unidos
Massachusetts General Hospital - Estados Unidos |
| 11 | Pineda-Salazar, David | - |
UNIV ANTIOQUIA - Colombia
Universidad de Antioquia - Colombia |
| 12 | Posada, Rafael | - |
UNIV ANTIOQUIA - Colombia
Universidad de Antioquia - Colombia |
| 13 | Roman, Norbel | - |
UNIV COSTA RICA - Costa Rica
Universidad de Costa Rica - Costa Rica |
| 14 | Sepulveda-Falla, Diego | Hombre |
Univ Klinikum Hamburg Eppendorf - Alemania
Universitätsklinikum Hamburg-Eppendorf - Alemania |
| 15 | Slachevsky, Andrea | - |
Centro de Gerociencia, Salud Mental y Metabolismo - Chile
Universidad de Chile - Chile Universidad del Desarrollo - Chile Clínica Alemana - Chile |
| 16 | Soto-Anari, Marcio | Hombre |
Univ Catolica San Pablo - Perú
|
| 17 | Tabilo, Evelyn | - |
Centro de Gerociencia, Salud Mental y Metabolismo - Chile
Universidad de Chile - Chile Universidad del Desarrollo - Chile Clínica Alemana - Chile |
| 18 | Vasquez, Daniel | - |
UNIV ANTIOQUIA - Colombia
Universidad de Antioquia - Colombia |
| 19 | Villegas-Lanau, Andres | - |
UNIV ANTIOQUIA - Colombia
Universidad de Antioquia - Colombia |
| Fuente |
|---|
| Universidad de Antioquia |
| Alzheimer's Association |
| National Institute of Neurological Disorders and Stroke |
| Massachusetts General Hospital |
| National Institute on Aging |
| Good Ventures |
| Executive Committee on Research |
| Agradecimiento |
|---|
| The authors thank Liliana Lopez, Liliana Hincapie, Alejandra Ruiz Rizzo, and Angela Andrade from the Grupo de Neurociencias, Universidad de Antioquia in Medellin, Colombia, for their help organizing this symposium. The authors also recognize Dr. Francisco Lopera for his lifetime dedication to studying Alzheimer's Disease and other dementias, as well as his invaluable contributions to the Resist Alzheimer Project during his time as coordinator of the Grupo de Neurociencias, Universidad de Antioquia in Medellin, Colombia. |
| This study was supported by gifts from Good Ventures (to Dr. Arboleda\u2010Velasquez and Dr. Sepulveda\u2010Falla), by grants (R01AG066823, RF1AG077627 to Dr. Quiroz) from the National Institute on Aging (NIA), by the Massachusetts General Hospital (MGH) Executive Committee on Research (MGH Research Scholar Award, to Dr. Quiroz), by a grant from the Alzheimer's Association (to Dr. Quiroz), by a grant (RM1NS132996, to Drs. Quiroz and Arboleda\u2010Velasquez) from the National Institute of Neurological Disorders and Stroke (NINDS). The funding sources had no role in the preparation, review, or approval of the manuscript, and decision to submit this manuscript for publication. |
| The authors thank Liliana Lopez, Liliana Hincapie, Alejandra Ruiz Rizzo, and Angela Andrade from the Grupo de Neurociencias, Universidad de Antioquia in Medellin, Colombia, for their help organizing this symposium. The authors also recognize Dr. Francisco Lopera for his lifetime dedication to studying\u00A0Alzheimer's Disease and other dementias, as well as his invaluable contributions to the Resist Alzheimer Project during his time as coordinator of the Grupo de Neurociencias, Universidad de Antioquia in Medellin, Colombia. This study was supported by gifts from Good Ventures (to Dr. Arboleda-Velasquez and Dr. Sepulveda-Falla), by grants (R01AG066823, RF1AG077627 to Dr. Quiroz) from the National Institute on Aging (NIA), by the Massachusetts General Hospital (MGH) Executive Committee on Research (MGH Research Scholar Award, to Dr. Quiroz), by a grant from the Alzheimer's Association (to Dr. Quiroz), by a grant (RM1NS132996, to Drs. Quiroz and Arboleda-Velasquez) from the National Institute of Neurological Disorders and Stroke (NINDS). The funding sources had no role in the preparation, review, or approval of the manuscript, and decision to submit this manuscript for publication. Consent was not necessary for this review. |